ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

NQO1/p65/CXCL12 Axis-Recruited Tregs Mediate Resistance to Anti-PD-1 Plus Lenvatinib Therapy in PIVKA-II-Positive Hepatocellular Carcinoma.

Biao Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.